Clinical Trial Update: Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating irinotecan liposome II combined with 5-FU/leucovorin, oxaliplatin, and Karelizumab for gastric cancer; currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-FU/LV (5-fluorouracil with leucovorin)
• Irinotecan Liposome II (irinotecan liposome)
• Karelizumab
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Gastric Cancer | Phase 2 | Status: NOT_YET_RECRUITING